Doximity price target lowered to $41 from $42 at Canaccord

Canaccord analyst Richard Close lowered the firm’s price target on Doximity to $41 from $42 and keeps a Buy rating on the shares. The analyst said although Doximity garners a stout valuation, the growth and profitability remain attractive, especially in an uncertain macro environment.